131 related articles for article (PubMed ID: 11181055)
1. Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells.
Makiishi-Shimobayashi C; Tsujimura T; Iwasaki T; Yamada N; Sugihara A; Okamura H; Hayashi S; Terada N
Biochem Biophys Res Commun; 2001 Feb; 281(2):361-6. PubMed ID: 11181055
[TBL] [Abstract][Full Text] [Related]
2. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype.
Varga F; Spitzer S; Klaushofer K
Calcif Tissue Int; 2004 Apr; 74(4):382-7. PubMed ID: 15255076
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
Nagai M; Sato N
Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850
[TBL] [Abstract][Full Text] [Related]
4. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.
Hofbauer LC; Shui C; Riggs BL; Dunstan CR; Spelsberg TC; O'Brien T; Khosla S
Biochem Biophys Res Commun; 2001 Jan; 280(1):334-9. PubMed ID: 11162519
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells.
Murakami T; Yamamoto M; Ono K; Nishikawa M; Nagata N; Motoyoshi K; Akatsu T
Biochem Biophys Res Commun; 1998 Nov; 252(3):747-52. PubMed ID: 9837778
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
Wada N; Maeda H; Yoshimine Y; Akamine A
Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
[TBL] [Abstract][Full Text] [Related]
7. Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells.
Chen Q; Kaji H; Kanatani M; Sugimoto T; Chihara K
Horm Metab Res; 2004 Oct; 36(10):674-8. PubMed ID: 15523591
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells.
Vidal ON; Sjögren K; Eriksson BI; Ljunggren O; Ohlsson C
Biochem Biophys Res Commun; 1998 Jul; 248(3):696-700. PubMed ID: 9703989
[TBL] [Abstract][Full Text] [Related]
10. Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells.
Shin HH; Kim SJ; Kang SY; Lee DS; Choi HS
Bone; 2006 Oct; 39(4):716-23. PubMed ID: 16750437
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.
Hofbauer LC; Dunstan CR; Spelsberg TC; Riggs BL; Khosla S
Biochem Biophys Res Commun; 1998 Sep; 250(3):776-81. PubMed ID: 9784422
[TBL] [Abstract][Full Text] [Related]
12. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts.
Tanabe N; Maeno M; Suzuki N; Fujisaki K; Tanaka H; Ogiso B; Ito K
Life Sci; 2005 Jun; 77(6):615-26. PubMed ID: 15921993
[TBL] [Abstract][Full Text] [Related]
13. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells.
McCarthy HS; Williams JH; Davie MW; Marshall MJ
J Cell Physiol; 2009 Feb; 218(2):350-4. PubMed ID: 18814141
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
[TBL] [Abstract][Full Text] [Related]
17. Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells.
Brändström H; Björkman T; Ljunggren O
Biochem Biophys Res Commun; 2001 Jan; 280(3):831-5. PubMed ID: 11162596
[TBL] [Abstract][Full Text] [Related]
18. Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2.
Fan X; Rahnert JA; Murphy TC; Nanes MS; Greenfield EM; Rubin J
J Cell Physiol; 2006 May; 207(2):454-60. PubMed ID: 16419041
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells.
Pantouli E; Boehm MM; Koka S
Biochem Biophys Res Commun; 2005 Apr; 329(1):224-9. PubMed ID: 15721297
[TBL] [Abstract][Full Text] [Related]
20. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells.
Horwood NJ; Elliott J; Martin TJ; Gillespie MT
Endocrinology; 1998 Nov; 139(11):4743-6. PubMed ID: 9794488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
